China Health Group Limited announced that it has entered into agreement for best effort basis private placement of Convertible Bond for gross proceeds of up to HKD 82,000,000 on June 9, 2022. The transaction will include participation from not less than six institutional, corporate or individual investors who are recognized as professional investors under the Securities and Futures Ordinance and who and whose ultimate beneficial owners are Independent Third Parties and not acting in concert with each other. The Convertible Bonds shall bear an interest from and including the date of issue of the Convertible Bonds to the Maturity Date at the rate of 6% per annum payable on a yearly basis and will mature on the second anniversary of the date of issue of the Convertible Bonds.

The notes are convertible into equity shares at an conversion price of HKD 0.10. The transaction is expected to close on July 15, 2022. The transaction will receive net proceeds of HKD 80,000,000.